Can a patient with a stomach ache take Ponstan (mefenamic acid)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can a Patient with Stomach Ache Take Ponstan (Mefenamic Acid)?

No, Ponstan (mefenamic acid) should not be taken for stomach ache, as NSAIDs including mefenamic acid can cause or worsen gastrointestinal symptoms and are contraindicated when abdominal pain is present without a clear non-GI diagnosis.

Why Ponstan Is Problematic for Stomach Ache

Gastrointestinal Toxicity Profile

  • Mefenamic acid causes significant gastrointestinal complications including gastritis, duodenitis, and bleeding ulcers, even at therapeutic doses 1
  • The drug can induce severe enteropathy with villous atrophy, particularly with prolonged use (>3 months), presenting as chronic diarrhea and weight loss 2
  • Unlike other NSAIDs, mefenamic acid specifically damages intestinal villi and causes malabsorption with steatorrhea 3

Clinical Reasoning

The fundamental issue is that stomach ache is a symptom, not a diagnosis. Without knowing the underlying cause, administering an NSAID like Ponstan could:

  • Mask serious pathology requiring urgent evaluation (appendicitis, pancreatitis, bowel obstruction)
  • Worsen existing GI inflammation if the pain stems from gastritis, peptic ulcer disease, or inflammatory bowel conditions
  • Create new GI injury through direct mucosal damage and prostaglandin inhibition

Appropriate Management Algorithm for Stomach Ache

First-Line Approach

For non-specific abdominal pain without alarm features:

  • Consider antispasmodics (hyoscine, dicyclomine) for cramping pain, particularly if meal-related 4
  • Proton pump inhibitors or H2-receptor antagonists for suspected gastritis or reflux 4, 5
  • Dietary modifications and hydration as supportive measures 6

Second-Line Options for Persistent Pain

If pain persists beyond simple measures:

  • Low-dose tricyclic antidepressants (amitriptyline 10 mg daily, titrated to 30-50 mg) for visceral pain modulation 4
  • These work as gut-brain neuromodulators and are more appropriate than NSAIDs for functional abdominal pain 4

When to Escalate

Red flags requiring immediate evaluation before any analgesic:

  • Severe or worsening pain
  • Associated fever, vomiting, or changes in bowel habits
  • History of peptic ulcer disease or GI bleeding
  • Recent medication changes (antibiotics, GLP-1 agonists) 6, 7

Critical Pitfalls to Avoid

The NSAID Trap

Many patients and providers reflexively reach for NSAIDs for any pain, but abdominal pain is the one scenario where NSAIDs are particularly dangerous. The gastrointestinal tract is both the site of pathology and the target organ for NSAID toxicity 1.

Delayed Diagnosis Risk

Using Ponstan for stomach ache may temporarily reduce pain through anti-inflammatory effects, creating false reassurance while serious pathology progresses. This is especially concerning for conditions like early appendicitis or mesenteric ischemia.

Cumulative Toxicity

Even if a single dose seems tolerable, mefenamic acid's enteropathy can develop insidiously with regular use, presenting weeks to months later with severe malabsorption 2.

Alternative Pain Management

If analgesia is absolutely necessary while determining the cause:

  • Acetaminophen (paracetamol) is safer for undifferentiated abdominal pain, though still not ideal
  • Antispasmodics provide targeted relief for cramping without mucosal injury 4
  • For confirmed diagnoses like dysmenorrhea (where Ponstan is actually indicated), the risk-benefit calculation changes entirely

The key principle: diagnose first, then treat appropriately based on the underlying cause rather than empirically suppressing symptoms with potentially harmful medications.

References

Research

Steatorrhea associated with meclofenamate sodium therapy.

The American journal of gastroenterology, 1987

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Abdominal Pain Associated with Antibiotic Use

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Abdominal Pain in Patients Taking Semaglutide

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.